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Abstract
G-protein coupled receptors (GPCRs) are a superfamily of cell signaling membrane proteins that include >750
members in the human genome alone. They are the largest family of drug targets. The vast diversity and relevance
of GPCRs contrasts with the paucity of structures available: only 21 unique GPCR structures have been
experimentally determined as of the beginning of 2013. User-friendly modeling and small molecule docking tools are
thus in great demand. While both GPCR structural predictions and docking servers exist separately, with GOMoDo
(GPCR Online Modeling and Docking), we provide a web server to seamlessly model GPCR structures and dock
ligands to the models in a single consistent pipeline. GOMoDo can automatically perform template choice, homology
modeling and either blind or information-driven docking by combining together proven, state of the art bioinformatic
tools. The web server gives the user the possibility of guiding the whole procedure. The GOMoDo server is freely
accessible at http://molsim.sci.univr.it/gomodo.
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Introduction
GPCRs are a vast superfamily of eukaryotic transmembrane
receptors which act as ubiquitously expressed key regulatory
elements and constitute more than 30% of current drug targets
[1]. Solving GPCR structures is notoriously technically
daunting: as of June 2013, structures for only 21 currently
unique GPCRs were available, less than 3% of the GPCR
diversity of the human genome. Thus, computational tools are
needed to obtain structural information for most GPCR-
targeting drug design and/or biophysical studies of receptor/
ligand interactions.
All GPCRs share a 7-helix membrane spanning architecture;
however the average sequence identity between members of
the superfamily is often below 20% [2], making target selection
and alignment required for homology modeling far from trivial.
Nonetheless, homology modeling has succeeded in predicting
ligand-target interactions information for several different
GPCRs [3–6]. In many cases, bioinformatic tools aided by
experimental validation have been crucial for accurate
structural characterization [7–11].
Both GPCR modeling servers/databases (GPCR-SSFE [12],
GPCR-ITASSER [13], and GPCR-ModSim [14]) and small
ligand docking servers exist (MEDock [15], PatchDock [16],
and SwissDock [17]). However, there is a lack of tools that
allow users to go seamlessly from sequence to docking, as well
as letting users guide the procedure with experimental data. An
additional hindrance is that a robust in silico approach to drug
design and ligand-receptor investigation requires mastering a
wide array of software tools, from alignment to modeling to
docking and structural refinement. Groups interested in ligand-
GPCR structural information do not necessarily have this
breadth of structural bioinformatics expertise; furthermore,
even users familiar with modeling and docking software may
find a quicker and reproducible method very useful. GOMoDo
is meant to allow both expert and non-expert users to obtain
readily, with minimum effort, biologically and pharmacologically
relevant results. GOMoDo, by itself, does not use any novel or
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untested method, but simply puts together state-of-the-art,
proven bioinformatic tools in an easy user interface. The
procedure herein automated has been already successfully
tested multiple times [8,11,44].
The GOMoDo Pipeline
The GOMoDo pipeline is briefly resumed in Figure 1. All the
programs used in the pipeline make use of the standard
parameters, unless noted.
Alignment and template choice
The server follows two possible routes (Fig. 1). Users can
upload a target sequence or can select one of the human
GPCRs available in a local database by using the name of the
receptor. A standard HHsearch protocol [18,19] is then used to
find structurally related templates from remotely homologous
sequences. Given that in some cases heuristic algorithms are
not accurate enough to obtain a reliable HMM for the target
[20], a good alignment is recommended for the generation of a
robust HMM profile. For the generation of the HMM, the users
can (i) choose to input an alignment of the target with relevant
sequences from the same subfamily, (ii) let the server calculate
such alignment, or (iii) in the case of human GPCRs, use one
of the pre-generated alignment present in the server. For the
latter case, sequences of the different GPCRs subclasses, as
obtained in the work by Almén and collaborators [21], were
aligned by us. We have used the program PROMALS [22],
following the same methodology as in refs. 8,11. If a user- or
database-provided alignment is not available, the initial multiple
sequence alignment is automatically generated by a search of
similar sequences, using either classic BLAST [23] or the
HMM-based search with HHblits [24]. The user can choose the
number of rounds of sequence search in either case.
Secondary structure information is added to the alignment
using PSI-PRED [25]. A hidden Markov model (HMM) is then
built and calibrated from the multiple alignment using HHmake
[19], matched to suitable templates of known structure with
HHsearch [19] using the database of HMMs available at ftp://
toolkit.lmb.uni-muenchen.de/pub/HHsearch/databases/.
Suitable templates are chosen from a complete set of GPCRs
three-dimensional structures (see Table S1 for a list of PDB
codes of available templates as of manuscript submission).
Templates and the corresponding HMM database are updated
every 1-2 months. Finally a structural alignment is produced for
each template using HHmakemodel. Before proceeding to
modeling, we allow the users to check the correctness of the
alignment with JALVIEW [26]. This procedure has been shown
previously to obtain template/target alignments useful for
homology modeling whenever the sequence similarity is low
but the overall fold similarity is high, as in the case of GPCRs
[8,11].
Homology modeling and model quality assessment
A user-chosen number of models is made for each template
using MODELLER9v10 [27] with standard single-template
parameters (Figure 1, users must have their own MODELLER
key). The user can also choose for automatic loop refinements
to be performed for each model by means of the standard
loopmodel class. For each model, GOMoDo outputs the
template PDB code, DOPE score (full and normalized) [28],
MOLPDF score [27] and GA341 score [29] as well as other
information A scatter plot of the GA341 vs. normalized DOPE
score for all models is available. Furthermore, models can be
Figure 1.  GOMoDo flow chart colored accordingly to the pipeline section.  Alignment and template choice, homology modeling
and model assessment, and docking sections are reported as light blue, light green and gray, respectively.
doi: 10.1371/journal.pone.0074092.g001
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directly submitted to the VADAR model quality assessment
server [30]. By using VADAR users can check more than 30
model quality indicators, which include structural descriptors
calculated by DSSP [31], WHATIF [32] or PROCHECK [33] like
the Ramachandran plot, fractional accessible surface area,
fractional volume, 3D quality index and stereo/packing quality
index. Upon completion of the modeling job, the user is notified
by an automatic e-mail sent by the server. Alternatively, the
modeling results can be retrieved directly from the webserver
up to 60 days later, by inserting the modeling job ID and/or e-
mail address. Alignment and modeling together can take from
several tens of minutes to several hours, depending on server
load and the number of requested homology models.
Advanced users may prefer to refine or modify the GOMoDo-
obtained models by themselves before proceeding to docking.
We allow users to upload custom models along with the ones
obtained in the output, and to compare them before
proceeding. In order to facilitate the user, we include a page
with the web links of other GPCRs modeling online tools.
Docking
GOMoDO can dock small molecules and peptides (i) blindly
(using AutoDock VINA [34], herein referred as VINA) or (ii)
using experimental information (using HADDOCK [35,36]) as
reported in Figure 1.
(i) VINA [34] is a fast, multithreaded and accurate rewriting of
AutoDock that often outperforms classical AutoDock both in
speed and quality [37,38]. A three-dimensional SDF or PDB file
of the ligand is all the input required. We also provide a library
of olfaction-related compounds from the OlfactionDB database
[39]. On the GOMoDo server, we can return ten VINA-docked
structures in less than a minute. VINA requires knowledge of
the location search space for conformations of the ligand --- in
other words, the generic location of the binding site. The server
already contains such information for all templates with respect
to the template PDB coordinate system; therefore before
docking, the model is structurally aligned with the templates
using LOVOALIGN [40] to guarantee that the search space box
is in the correct position with respect to the model coordinate
system. In simple cases (small ligands and targets close in
sequence to a modeling template) GOMoDo with VINA can
yield quick and reasonable results.
(ii) Available experimental information on the residues
involved in ligand binding such as NMR titration experiments or
mutagenesis data can be used to guide docking. This can be of
crucial importance when docking is based on non-trivial
homology models, as is often the case for GPCRs. We
therefore offer an interface to the HADDOCK software [35,36],
where the user can indicate explicitly the protein residues
involved in the receptor-ligand interaction. HADDOCK performs
a slower but more refined docking than VINA. In particular,
HADDOCK includes a final refinement step with molecular
dynamics in explicit water which allows for flexibility of specified
residues. This feature has the further positive side effect of
including side-chain optimization of the binding cavity. While
advanced users can take advantage of the online official
HADDOCK server [41] for this (which gives full control over all
docking options), we also offer a simplified in-house interface
to the HADDOCK software that allows the docking of ligands,
peptides or interacting proteins. If the ligand is a small non-
protein molecule, HADDOCK requires parameter files with
partial charges for the ligand, as well as CNS parameter files.
Users can obtain them from PRODRG [42] or produce them
using their own calculations. GOMoDo allows downloading the
entire HADDOCK output either as a compressed archive,
individual clusters or single output structures. HADDOCK
advanced refinement is also attractive when experimental
information is missing. To use HADDOCK for blind docking in
GOMoDo, the user can analyze the model on the server with
FPOCKET [43] and obtain in a few seconds predictions of
plausible binding pockets; in the Supplementary Information,
we give two successful examples of this usage (Figure S1).
FPOCKET is also useful for obtaining accessory information for
experiment-guided docking.
Application Cases
The methodology automatized in GOMoDo has been already
used to structurally characterize ligand-GPCRs adducts
[8,11,44]. To assess the server, we tested GOMoDo by
reproducing selected examples of known GPCR-ligand
complexes present in the PDB (targets). In every case we
mimicked what a standard user would do, as advised by the
manual. For the selected PDB complexes we took the full
protein sequence from UniProt and generated 30 models per
template using the default BLAST alignment for HMM
generation. We then picked up the best model according to
DOPE and GA341 scores, obviously excluding models built on
the structure of the target. The ligands present in the crystal
structure were then docked to the model using VINA or
HADDOCK programs.
Here we describe three examples of applications (Figure 2):
the first example is a simple application using the human
beta-2 adrenergic receptor (hβ2AR) that has been previously
used by some of us as a test case [44]. The second example is
the modeling of human dopamine D3 receptor (hD3R), a
slightly more complex case because of the low sequence
identity between the receptor and the templates. Finally, the
third example deals with the human A2A adenosine receptor
(hA 2AR) in complex with the antagonist ligand ZM241385
(ZMA). In this case, some difficulties can be expected because
the antagonist is a rather bulky molecule. Other application
examples, which can be found in Figure S1, deal with the
human histamine H1 receptor and human kappa-opioid
receptor.
hβ2AR
The structure of the hβ2AR (UniProt ID: P07550) was
modeled using as a template the structure of the turkey beta-1
adrenergic (tβ1AR) receptor (PDB entry: 2Y00 [45], UniProt ID:
P07700). The sequence identity between the two receptors is
about 46.1% and thus the model is indeed of relatively good
quality [Cα root mean square deviation (rmsd) = 1.3 Å].
Furthermore, the ligand is relatively small and thus it probably
does not require significant conformational changes of the side
chains to fit in the binding cavity. We docked the ligand
GPCRs Online Modeling and Docking Webserver
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carazolol to the hβ2AR model with fast VINA and compared our
results against the experimentally determined X-ray structure
(PDB code: 2RH1 [46]). The resulting structure of the ligand-
receptor complex is in fair agreement with the crystal structure,
in terms of both the ligand pose and the side-chains orientation
(Figure 2A, rmsd calculated on heavy atoms = 2.9 Å).
hD3R
VINA can also give reasonable results when used with
distant homology models. We modelled hD3R (UniProt ID:
P35462) in complex with the antagonist eticlopride, and
compared the results with the corresponding crystal structure
(PDB code: 3PBL [47]). The best template in this case was
Figure 2.  Reproducing GPCR-ligand complexes with GOMoDo.  hβ2AR (A), hD3R (B) and hA 2AR (C,D) binding sites in the
immediate neighbourhood of ligands for crystal structures and models obtained with GOMoDo. The homology model and the
docked ligand are orange and red, respectively. The experimental structure and ligand are cyan and blue, respectively. (A) VINA
docking of carazolol to the hβ2AR model and compared to the crystal structure (PDB: 2RH1). (B) VINA docking of eticlopride to the
hD3R model and compared to the crystal structure (PDB: 3PBL). HADDOCK (C) and VINA (D) docking of ZMA to the hA 2AR
compared with the crystal structure (PDB: 3EML). Insert in D shows the unphysical artefacts generated by the VINA docking.
doi: 10.1371/journal.pone.0074092.g002
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human sphingosine-1 phosphate receptor (PDB code: 3V2Y
[48], UniProt ID: P21453), with a sequence identity of 22.1%.
Despite the relatively poor modelling of loops in the binding
site, the orientation of the binding pose is correct (Figure 2B,
rmsd = 4.0 Å).
hA2AR
An example of a harder task is reproducing the structure of
hA 2AR in complex with ZMA, whose crystal structure is
available as PDB code 3EML [49] (UniProt ID: P29274). Here,
the best template, which happens to be again the tβ1AR (PDB:
2Y00) structure, shares only 28.1% of sequence identity with
the target. Hence, the model can be expected to be less
accurate (model/target Cα rmsd = 4.0 Å) than the one
previously described. In this case, the antagonist is also
significantly bulkier. We therefore used HADDOCK [35,36] and
we set inter-molecular interactions between the ligand and
residues Asn253, Met270, Ile274, Ser277, and His250 as
active restraints. We also used the best FPOCKET predicted
binding pocket - which encompassed the binding residues - as
passive restraints (that is, the residues that HADDOCK is given
permission to move to accommodate the ligand). Default
options of HADDOCK and default PRODRG settings for ligand
were used. The best structure of the most populated
HADDOCK-derived cluster, (Figure 2C) is very similar to that of
the X-ray structure (rmsd = 2.1 Å) [49].
The third case (the modeling of hA 2AR) shows that
advanced docking methods are often required to obtain
reasonable structures. Docking of ZMA to the hA 2AR model
structure with VINA fails: the ligand is shifted from the correct
binding site and flipped by 180 degrees on two axes (Figure
2D, rmsd = 10.5 Å). Moreover, even the VINA best structure in
this case shows gross clashes between the ligand and protein
side chains due to the difficulty in accommodating the ligand
while treating the protein as rigid (Figure 2D, insert). Notice that
even if the starting model is the same for VINA and
HADDOCK, the backbone and side chain orientation of models
is slightly different and often closer to the experimental
structure in the latter. This is due to the flexible refinement of
HADDOCK performed in explicit solvent, while VINA treats the
model as rigid. In Figures S1A and S1B, we show how
HADDOCK can also be useful in the absence of experimental
information by using FPOCKET to obtain restrains.
Conclusions
GOMoDo is intended to be a user friendly pipeline that puts
together several state-of-the-art tools and allows experienced
and inexperienced users to obtain GPCR’s homology models
together with predictions of ligand binding poses. GOMoDo
was developed to be flexible and adaptable to the user’s
demands. For this reason, every step of the GOMoDo pipeline
allows user intervention (if needed) to i) insert alignments, ii)
use homology models generated by other methods, iii) predict
binding cavities and iv) include experimental restraints for
performing knowledge-based virtual docking experiments. The
combination of all these tools in a single publicly available web
server is GOMoDo’s novelty. In particular, the possibility of
interacting with the server all along the pipeline allows the user
to include experimental information from molecular biology
experiments into the process, preventing it from becoming a
fully-automatic black-box.
Supporting Information
Table S1.  GPCR structures available as templates in
GOMoDo as of June 2013. Note that the template database is
regularly updated every 1-2 months.
(DOCX)
Figure S1.  Further examples of GOMODO in action.
Receptor binding sites in the immediate neighbourhood of
ligands for crystal structures and models obtained with
GOMoDo. The homology model and the docked ligand are
orange and red, respectively. The experimental structure and
ligand are cyan and blue, respectively.
Here we show examples of successful blind HADDOCK
docking, exploiting FPOCKET to guess residues involved in the
binding cavity. All the residues corresponding to the best
FPOCKET-calculated binding cavity were used as both active
and passive restraints. (A) Human histamine H1 receptor
(UniProt ID: P35367) in complex with trans-doxepin: model and
docking compared with crystal structure (PDB code: 3RZE).
Model template is human M2 muscarinic acetylcholine receptor
(PDB code: 3UON, UniProd ID: P08172). (B) Human kappa-
opioid receptor (UniProt ID: P41145) in complex with the bulky
and flexible ligand JDTic: model and docking compared with
crystal structure (PDB code: 4DJH). Model template is the
mouse μ-opioid receptor (PDB structure: 4DKL, UniProt ID:
P42866). In this case the pose is slightly shifted with respect to
the crystal structure and rotameric state is different; however
position and global orientation are correct. Here nitrogen atoms
are in dark green and oxygen atoms in cornflower blue.
(TIF)
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